Gastrointestinal Flashcards
Liver segments by portal and hepatic veins
Portal vein: superior/inferior
Middle hepatic vein: right/left
Left hepatic vein: 2,3/4
Right hepatic vein: 5,8/6,7
Hepatic segment vasculature
Central:
portal triad—> portal vein, hepatic artery, bile duct
Peripheral:
venous —>hepatic vein—>IVC
Caudate:
Direct to the IVC
Routine contrast enhanced CT usage
Portal venous phase(70s after injection)
Hepatic steatosis, cirrhosis
Most metastasis ( not hyper vascular)
Some breast Mets are iso in portal phase/detected on unenhanced
Arterial phase CT usage in liver
20-25 s after injection
Primary liver masses (hyper vascular)
Optimal view—> late arterial (35 s)
NAFLD categories
Steatosis
Steatohepatitis
Metabolic syndrome
NAFLD
Obesity
Insulin resistance
Dyslipidemia
Hepatic steatosis on CT
Un-enhanced:
Liver attenuated 10 HU less than spleen
Contrast enhanced: liver 25 HU less than spleen in pvp
Fatty liver on MRI
In and out of phase GRE MRI
complete signal loss on out of phase
In phase: water+fat
Out of phase:water-fat
Decreased signal on in phase MRI
Hepatic iron overload
Increases TE—> longer dephasing—> exaggerated T2*
Focal liver fat characteristics
No mass effect
Vessels run through it
Location:
Gallbladder fossa/ subcapsular/periportal/
Hyper echo on US and hypo on CT
Liver amyloidosis
Decreased attenuation on CT
Wilson disease on CT
Copper : basal ganglia/cornea/liver
Liver:
Hyper on CT—> multiple nodules—>hepatomegaly—>cirrhosis
Excess hepatic iron accumulation pathways
Within hepatocytes: hemochromatosis
Increased uptake in RES: kupffer cells/ hemosiderosis
Iron overload liver imaging
MRI: hypo compared to paraspinal muscle
Hemochromatosis vs Hemosiderosis
Hemochromatosis: spleen and bone marrow are spared
Involves pancreas,myocardium,skin,joint/ cause cirrhosis/ tx: phlebotomy
Hemosiderosis: spleen and bone marrow are involved/ no cirrhosis/ tx: iron chelator
Hypo-attenuated liver on CT
Fatty liver Hepatic amyloid ( rare)
Hyper attenuated liver on CT
>75 HU iron overload Medication: amiodarone, gold, methotrexate Copper overload Glycogen excess
Viral hepatitis imaging
Normal CT
Gallbladder wall thickening
Periportal edema
DDx for multiple tiny hypo hepatic lesions
Candidiasis (involves spleen/ rim enhanced/ immunocompromised)
Mets
Lymphoma
Biliary hamartoma
Caroli disease (dilatation of intrahepatic bile ducts/fibrocystic anomalies of the kidneys)
Causes of liver abscess
Diverticulitis Appendicitis Crohn Bowel surgery Ascending cholangitis ( less common)
E.Coli
Hepatic abscess on imaging
Mimics Mets
CT: ring enhanced
MRI: central hyper on T2/ irregular wall with late enhancement/ perilesional enhancement
Hepatic echinococcosis on imaging
CT: well defined hypo mass with floating membrane and peripheral calcification
US: hypoechoic mass with hyperechoic undulating membrane
Cirrhosis forms
Micronodular: metabolic causes
Macronodular: post viral
Cirrhosis on imaging
Early: preportal space expansion Caudate enlargement Caudate/right lobe>0.65 Empty gallbladder fossa sign
Secondary:
Portal HTN—> splenomegaly, portosystemic collaterals, varies
Gall bladder wall thickening
Gamna-Gandy bodies( splenic microhemorrhage)
Regenerative liver nodules on imaging
Supplied by portal vein/ non pre malignant
No enhancement on arterial phase
Low on T2
Contrast enhanced MRI: iso to liver parenchyma
Dysplastic liver nodule on imaging
Premalignant/ supplied by portal vein Mostly don’t enhance Hypo on T2 High grade: hyper on T2 Contrast enhanced: Low grade—> iso to liver High grade—> arterial enhancement
Siderotic liver nodule on imaging
Iron rich regenerative or dysplastic nodule
Hypo on T1 and T2*
Hyper on CT
HCC on CT and MRI
Encapsulate
Enhances on arterial and washes out on portal venous
Hyper on T2
10-20% of HCCs are hypoenhancing
Nodule in nodule appearance
Enhancing nodule in a dysplastic nodule
Early HCC
HCC invasion pattern
Port, portal veins, IVC and bile ducts
Mets to the liver are less locally invasive
HCC treatment
Hepatectomy
Transplant
Percutaneous ablation
Transcatheter embolization
Fibrolamellar carcinoma
HCC subtype
Young patient without cirrhosis
AFP not elevate
Better prognosis
Fibrolamellar carcinoma on imaging
Large, heterogenous Fibrotic central scar: hypo on T1 and T2 Focal nodular hyperplasia: T2 hyper with delayed enhancement Capsular retraction in 10% Do not have capsule Have pseudocapsule
Liver metastasis imaging
Mostly hypovascular
Seen on portal venous phase
Calcification: mucinous colorectal/ ovarian serous
MRI: hypo T1/hyper T2
Hyper vascular liver metastasis
Neuro endocrine tumors RCC Thyroid carcinoma Melanoma Sarcoma
Pseudocirrhosis
Multiple hepatic metastasis
Treated breast cancer
Can have capsular retraction
Hepatic lymphoma
Primary is rare
Usually secondary with splenomegaly and LAP
Epithelioid hemangioendothelioma
Vascular malignancy
Multiple round subcapsular masses that can be confluent
Can have halo or target
Capsular retraction
DDx for capsular retraction
Metastatic tumors Fibrolamellar HCC HCC epithelioid hemangioendothelioma Intrahepatic cholangiocarcinoma Confluent hepatic fibrosis: wedge shaped Cirrhosis Medial left/ anterior right
Focal nodular hyperplasia
Disorganized tissue
Not malignant
More in women
Not associated with OCP
FNH in imaging
Central scar (not true scar) is T2hyper ductules and venules, with delayed enhancement
Avid enhancement on arterial with quick wash out
Has kupffer cells (sulfur colloid study) and bile duct (HIDA scan)
Hepatic hemangioma
Benign
Hepatic artery at the periphery
More female
Uncommon in cirrhosis
Hepatic hemangioma
Nonenhancing center ( cystic degeneration)
Peripheral, discontinuous, progressive, nodular enhancement
SI is identical to aorta
Hyper on T2 with even subtle areas of even higher SI ( cystic degeneration)
On CT: hypo mass
Hepatic adenoma
Benign Hepatocyte Kupffer cells No bile ducts More in females With OCP High risk of hemorrhage Multiple: von Gierke disease
Hepatic adenoma on imaging
Might have pseudocapsule with late enhancement
Hyper on arterial
Microscopic fat on in and out phase
Internal hemorrhage: T1 hyper
Budd Chiari causes
Hepatic venous obstruction Hypercoag state Hematologic disease, pregnancy, OCP Malignancy, infection,trauma Congenital vein anomaly
Budd Chiari symptoms
Acute: hepatomegaly, ascites, abdominal pain
Lack of flow in hepatic vein Thrombus in IVC Collateral vessels Edematous periphery Caudate sparing Prominent regen nodules
Veno-occlusive disease
Destruction of post sinusoid all venules
Patent hepatic vein
In BM transplant due to chemo
Imaging: peripheral edema Narrow hepatic vein Hepatomegaly Hetero enhancement Caudate is not spared
Cardiac hepatopathy
Heart failure
Constrictive pericarditis
Right valvular disease
Imaging: enlarged vein and IVC
reflux of contrast from Right atrium into IVC
Mottled enhancement
Biliary hamartomas
Von Meyenburg complex
Incidental
Small cystic lesions
Embryologic failure
Smaller and more irregular than simple cysts
ADPLD
40% of ADPKD
Similar findings
Failure is rare
Imaging: innumerable no enhancing simple cyst
MDCT hepatic trauma
Grade1: superficial laceration,subcapsular hematoma<1cm
Grade 2: laceration, subcapsular/intraparenchymal hematoma>1 <3 cm
Grade3: >3cm
Grade 4: hematoma>10cm or destruction of one lobe
Grade 5: destruction of both lobes
Magnetic resonance cholangiopancreatography
Heavy T2 weighted
Increase contrast between biliary tract and surroundings
Fast spin echo sequences
Intermediate T2: evaluate extraluminal structures
Gad contrasts with biliary excretion
Gadoxetic acid disodium ( Eovist) Gadobenate dimeglumine (Multihance)
Require 20-45 minutes delay
T1 hyper biliary fluid
Choledochal cysts classification
Todani system:
Type1: CBD fusiform/ most common
Type2:extrahepatic saccular
Type3:intraduodenal
Type4:multiple segments
Type5:intrahepatic/ caroli/ associated with PKD
Caroli syndrome: disease+hepatic fibrosis
Imaging:central dot sign(portal vein and hepatic artery bridging bile ducts)
Increase risk of cholangiocarcinoma
Cholecystitis
Obstruction of GB neck or cystic duct Acute: Wall thickness >3cm Pericholecystic fluid GB hyperemia GB calculi